Nicotinic receptors regulate the dynamic range of dopamine release in vivo

Journal of Neurophysiology

Volumn 111, Issue 1, 2014, Pages 103-111

  Koranda, Jessica L ^a   Cone, Jackson J ^b   McGehee, Daniel S ^a   Roitman, Mitchell F ^b   Beeler, Jeff A ^a,c   Zhuang, Xiaoxi ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

nicotinic subunit; Chronic nicotine; Dopamine release; Dorsolateral striatum; In vivo cyclic voltammetry

Indexed keywords

DOPAMINE; NICOTINE; NICOTINIC RECEPTOR BETA2;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; FEMALE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; STIMULUS RESPONSE;

CHRONIC NICOTINE; DOPAMINE RELEASE; DORSOLATERAL STRIATUM; IN VIVO CYCLIC VOLTAMMETRY; Β2 NICOTINIC SUBUNIT;

ACTION POTENTIALS; ANIMALS; DOPAMINE; EXOCYTOSIS; MICE; MICE, INBRED C57BL; RECEPTORS, NICOTINIC; SUBSTANTIA NIGRA;

EID: 84891506984     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00269.2013     Document Type: Article

References (86)

1. Balleine BW, Delgado MR, Hikosaka O. The role of the dorsal striatum in reward and decision-making. J Neurosci 27: 8161-8165, 2007.
2. Beeler JA. Preservation of function in Parkinson's disease: what's learning got to do with it? Brain Res 1423: 96-113, 2011.
3. Beeler JA, Cao ZF, Kheirbek MA, Ding Y, Koranda J, Murakami M, Kang UJ, Zhuang X. Dopamine-dependent motor learning: insight into levodopa's long-duration response. Ann Neurol 67: 639-647, 2010.
4. Beeler JA, Frank MJ, McDaid J, Alexander E, Turkson S, Bernandez MS, McGehee MS, Zhuang X. A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease. Cell Rep 2: 1747-1761, 2012.
5. Berridge KC. Motivation concepts in behavioral neuroscience. Physiol Behav 81: 179-209, 2004.
6. Berridge KC, Robinson TE, Aldridge JW. Dissecting components of reward: 'liking', 'wanting', and learning. Curr Opin Pharmacol 9: 65-73, 2009.
7. Buisson B, Bertrand D. Chronic exposure to nicotine upregulates the human alpha4beta2 nicotinic acetylcholine receptor function. J Neurosci 21: 1819-1829, 2001.
8. Cachope R, Mateo Y, Mathur BN, Irving J, Wang HL, Morales M, Lovinger DM, Cheer JF. Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing. Cell Rep 2: 33-41, 2012.
9. Calabresi P, Picconi B, Tozzi A, Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30: 211-219, 2007.
10. Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C, Clementi F, Moretti M, Rossi FM, Le Novere N, McIntosh JM, Gardier AM, Changeux JP. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci 23: 7820-7829, 2003.
11. Changeux JP. Nicotine addiction and nicotinic receptors: lessons from genetically modified mice. Nat Rev Neurosci 11: 389-401, 2010.
12. Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, Umbach DM, Xu Q, Hollenbeck A, Schatzkin A, Blair A. Smoking duration, intensity, and risk of Parkinson disease. Neurology 74: 878-884, 2010.
13. Day JJ, Roitman MF, Wightman RM, Carelli RM. Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens. Nat Neurosci 10: 1020-1028, 2007.
14. Even N, Cardona A, Soudant M, Corringer PJ, Changeux JP, Cloez-Tayarani I. Regional differential effects of chronic nicotine on brain alpha4-containing and alpha6-containing receptors. Neuroreport 19: 1545-1550, 2008.
15. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481-1489, 2005.
16. Exley R, Clements MA, Hartung H, McIntosh JM, Cragg SJ. Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33: 2158-2166, 2008.
17. Exley R, Cragg SJ. Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission. Br J Pharmacol 153, Suppl 1: S283-S297, 2008.
18. Exley R, McIntosh JM, Marks MJ, Maskos U, Cragg SJ. Striatal5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum. J Neurosci 32: 2352-2356, 2012.
19. Gorell JM, Rybicki BA, Johnson CC, Peterson EL. Smoking and Parkinson's disease. Neurology 52: 115-119, 1999.
20. Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, Zanardi A, Rimondini R, Mugnaini M, Clementi F, Chiamulers C, Zoli M. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion and reinforcement. J Neurosci 30: 5311-5325, 2010.
21. Govind AP, Vezina P, Green WN. Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction. Biochem Pharmacol 78: 756-765, 2009.
22. Govind AP, Walsh H, Green WN. Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J Neurosci 32: 2227-2238, 2012.
23. Grabus SD, Martin BR, Bartman AM, Tyndale RF, Sellers E, Damaj MI. Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology (Berl) 178: 183-192, 2005.
24. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4: 2877-2890, 1984.
25. Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol 74: 1235-1246, 2007.
26. Hartman KN, Pal SK, Burrone J, Murthy VN. Activity-dependent regulation of inhibitory synaptic transmission in hippocampal neurons. Nat Neurosci 9: 642-649, 2006.
27. Hollander JA, Pham D, Fowler CD, Kenny PJ. Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence. Front Behav Neurosci 6: 47, 2012.
28. Humphries MD, Prescott TJ. The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Prog Neurobiol 90: 385-417, 2010.
29. Hyland BI, Reynolds JNJ, Hay J, Perk CG, Miller R. Firing modes of midbrain dopamine cells in the freely moving rat. Neuroscience 114: 475-492, 2002.
30. Johnson PM, Hollander JA, Kenny PJ. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Pharmacol Biochem Behav 90: 409-415, 2008.
31. Kenny PJ, Polis I, Koob GF, Markou A. Low dose cocaine self-administration transiently increases but high dose cocaine persistently decreases brain reward function in rats. Eur J Neurosci 17: 191-195, 2003.
32. Kenny PJ, Markou A. Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. J Neurosci 25: 6208-6212, 2005.
33. Kenny PJ, Markou A. Nicotine self-administration acutely activates reward systems and induces and long-lasting increase in reward sensitivity. Neuropsychopharmacology 31: 1203-1211, 2006.
34. Kenny PJ, Chen SA, Kitamura O, Markou A, Koob GF. Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 26: 5894-5900, 2006.
35. Kheirbek MA, Britt JP, Beeler JA, Ishikawa Y, McGehee DS, Zhuang X. Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning. J Neurosci 29: 12115-12124, 2009.
36. Kile BM, Guillot TS, Venton BJ, Wetsel WC, Augustine GJ, Wightman RM. Synapsins differentially control dopamine and serotonin release. J Neurosci 30: 9762-9770, 2010.
37. Lerner TN, Kreitzer AC. Neuromodulatory control of striatal plasticity and behavior. Curr Opin Neurobiol 21: 322-327, 2011.
38. Maffei A, Nataraj K, Nelson SB, Turrigiano GG. Potentiation of cortical inhibition by visual deprivation. Nature 443: 81-84, 2006.
39. Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP, Faure P. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50: 911-921, 2006.
40. Marks MJ, McClure-Begley TD, Whiteaker P, Salminen O, Brown RW, Cooper J, Collins AC, Lindstrom JM. Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced upregulation of nicotinic agonist binding sites in mouse brain. J Pharmacol Exp Ther 337: 187-200, 2011.
41. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallkum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zierger JM. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190: 269-319, 2007.
42. McCallum SE, Parameswaran N, Bordia T, Fan H, McIntosh JM, Quik M. Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term nicotine to monkeys. J Pharmacol Exp Ther 318: 381-388, 2006a.
43. McCallum SE, Parameswaran N, Bordia T, Fan H, Tyndale RF, Langston JW, McIntosh JM, Quik M. Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment. J Neurochem 96: 1028-1041, 2006b.
44. Meliska CJ, Bartke A, McGlacken G, Jensen RA. Ethanol, nicotine, amphetamine and aspartame consumption and preferences in C57BL/6 and DBA/2 mice. Pharmacol Biochem Behav 50: 619-626, 1995.
45. Morens DM, Grandinetti A, Reed D, White LR, Ross GW. Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology 45: 1041-1051, 1995.
46. 125I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine. Neuroscience 137: 565-572, 2006.
47. 3H]methylcaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. Eur J Neurosci 16: 1633-1646, 2002.
48. Nashmi R, Xiao C, Deshpande P, McKinney S, Grady SR, Whiteaker P, Huang Q, McClure-Begley T, Lindstrom JM, Labarca C, Collins AC, Marks MJ, Lester HA. Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci 27: 8202-8218, 2007.
49. Nguyen HN, Rasmussen BA, Perry DC. Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther 307: 1090-1097, 2003.
50. Nicola SM. The nucleus accumbens as part of a basal ganglia action selection circuit. Psychopharmacology (Berl) 191: 521-550, 2007.
51. Perez XA, Bordia T, McIntosh JM, Grady SR, Quik M. Long-term nicotine treatment differentially regulates striatal 6 4 β* and 6(non 4) β* nAChR expression and function. Mol Pharmacol 74: 844-853, 2008.
52. Perez XA, O'Leary KT, Parameswaran N, McIntosh JM, Quik M. Prominent role of alpha/alpha6betaβ* nAChRs in regulation evoked dopamine release in primate putamen: effect of long-term nicotine treatment. Mol Pharmacol 75: 938-946, 2009.
53. Perry DC, Mao D, Gold AB, McIntosh JM, Pezzullo JC, Kellar KJ. Chronic nicotine differentially regulates alpha6-and beta3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 322: 306-315, 2007.
54. Phillips PE, Stuber GD, Heien ML, Wightman RM, Carelli RM. Subsecond dopamine release promotes cocaine seeking. Nature 422: 614-618, 2003.
55. Picciotto MR, Zoli M, Zachariou V, Changeux JP. Contribution of nicotinic acetylcholine receptors containing the beta 2-subunit to the behavioural effects of nicotine. Biochem Soc Trans 25: 824-829, 1997.
56. Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Pich EM, Fuxe K, Changeux JP. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177, 1998.
57. Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci 27: 561-568, 2004.
58. Quik M, Wonnacott S. α6β* and α4 β* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol Rev 63: 938-966, 2011.
59. Redgrave P, Vautrelle N, Reynolds JNJ. Functional properties of the basal ganglia's re-entrant loop architecture: selection and reinforcement. Neuroscience 198: 138-151, 2011.
60. Reynolds JN, Wickens JR. Dopamine-dependent plasticity of corticostriatal synapses. Neural Netw 15: 507-521, 2002.
61. Rice ME, Cragg SJ. Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7: 583-584, 2004.
62. Robinson SF, Marks MJ, Collins AC. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl) 124: 332-339, 1996.
63. Roitman MF, Stuber GD, Phillips PE, Wightman RM, Carelli RM. Dopamine operated as a subsecond modulator of food-seeking. J Neurosci 24: 1265-1271, 2004.
64. Roitman MF, Wescott S, Cone JJ, McLane MP, Wolfe HR. MSI-1436 reduces acute food intake without affecting dopamine transporter activity. Pharmacol Biochem Behav 97: 138-143, 2010.
65. Rowell PP, Hurst HE, Marlowe C, Bennett BD. Oral administration of nicotine: its uptake and distribution after chronic administration to mice. J Pharmacol Methods 9: 249-261, 1983.
66. Salamone JD, Correa M, Farrar A, Mingote SM. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) 191: 461-482, 2007.
67. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, Grady SR. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65: 1526-1535, 2004.
68. Schultz W. Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey. J Neurophysiol 56: 1439-1461, 1986.
69. Schultz W. Getting formal with dopamine and reward. Neuron 36: 241-263, 2002.
70. Shen W, Flajolet M, Greengard P, Surmeier DJ. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321: 848-885, 2008.
71. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, Lester HA. Nicotinic activation of 4* receptors: sufficient for reward, tolerance and sensitization. Science 306: 1029-1032, 2004.
72. Tapper AR, McKinney SL, Marks MJ, Lester HA. Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice. Physiol Genomics 31: 422-428, 2007.
73. Threlfell S, Cragg SJ. Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. Front Syst Neurosci 5: 11, 2011.
74. Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, Cragg SJ. Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75: 58-64, 2012.
75. Turrigiano G. Too many cooks? Intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement. Annu Rev Neurosci 34: 89-103, 2011.
76. Vallejo YF, Buisson B, Bertrand D, Green WN. Chronic nicotine upregulates nicotinic receptors by a novel mechanism. J Neurosci 25: 5563-5572, 2005.
77. van Zessen R, Phillips JL, Budygin EA, Stuber GD. Activation of VTA GABA neurons disrupts reward consumption. Neuron 73:1184-1194, 2012.
78. Venton BJ, Siepel AT, Phillips PE, Wetsel WC, Gitler D, Greengard P, Augustine GJ, Wightman RM. Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26: 3206-3209, 2006.
79. Walsh H, Govind AP, Mastro R, Hoda JC, Bertrand D, Vallejo Y, Green WN. Up-regulation of nicotinic receptors by nicotine varies with receptor subtype. J Biol Chem 283: 6022-6032, 2008.
80. Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, Lester HA. Chronic nicotine selectively enhances 4 β*nAChRs in the nigrostriatal dopamine pathway. J Neurosci 29: 12428-12439, 2009.
81. Yang K, Buhlman L, Khan GM, Nichols RA, Jin G, McIntosh JM, Whiteaker P, Lukas RJ, Wu J. Functional nicotinic acetylcholine receptors containing 6 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons. J Neurosci 31: 2537-2548, 2011.
82. Zhang H, Sulzer D. Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 7: 581-582, 2004.
83. Zhang L, Doyon WM, Clark JJ, Phillips PE, Dani JA. Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol Pharmacol 76: 396-404, 2009a.
84. Zhang T, Zhang L, Liang Y, Siapas AG, Zhou FM, Dani JA. Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. J Neurosci 29: 4035-4043, 2009b.
85. Zhou FM, Liang Y, Dani JA. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4: 1224-1229, 2001.
86. Zhuang X, Mazzoni P, Kang UJ. The role of neuroplasticity in dopaminergic therapy for Parkinson disease. Nat Rev Neurol 9: 248-256, 2013.